Skip to main content
Premium Trial:

Request an Annual Quote

GeneMatters, Clear Genetics Partner on Telehealth-Based Genetic Counseling

NEW YORK (GenomeWeb) – Telehealth genetic counseling service provider GeneMatters is joining with Clear Genetics, maker of a chatbot that helps counselors triage cases, to offer a combined human-automated system to healthcare providers. This combination is intended to address the ongoing shortage of genetic counselors.

Patients signing on to a health system's genetic telehealth portal will first go through Gia, the automated triage engine from Clear Genetics, a San Francisco-based startup that came through the Y Combinator business accelerator. Complex cases would be handed off to live GeneMatters counselors, the companies said today.

"This partnership allows us to provide a robust, turnkey solution for our customers looking to simplify the delivery of genetic services. From pretest to return of results and ongoing care, patients will have Gia at their fingertips and GeneMatters a phone call away," Clear Genetics CEO Moran Snir said in a statement.

"This partnership with Clear Genetics wholly supports our mission to help more patients, while personalizing and improving the efficiency of healthcare delivery," added Jill Davies, CEO and cofounder of Minneapolis-based GeneMatters.

Both companies count hospitals, large health systems, medical clinics, genetic testing labs, and employers as customers. They cover fields including hereditary cancer, reproductive health, cardiology, and neurology.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.